Et Browne (UK) Limited
Registered name: ET BROWNE (UK) LIMITED
Et Browne (UK) Limited made £27.9m revenue and £848k profit in the year to 28 Feb 2025.
Et Browne (UK) Limited’s revenue grew 6% to £27.9m in the year to 28 Feb 2025, with £848k profit and 20 employees. The company is classified under “wholesale of pharmaceutical goods”; we hold 3 years of its filed accounts.
- Status
- Active
- Location
- London
- Age
- 33 yrs · since 1992
- Type
- Private Limited Company
Key figures
Badges are automated estimates derived from the filed figures — not statements of fact about the company.
Financial history
| Year to | 28 Feb 2023 | 29 Feb 2024 | 28 Feb 2025 |
|---|---|---|---|
| Disclosure | No P&L | Full P&L | Full P&L |
| Profit & loss | |||
| Revenue (turnover) | — | £26.4m | £27.9m |
| Operating profit | — | £1.3m | £1.1m |
| Profit before tax | — | £1.3m | £1.1m |
| Profit after tax | — | £984k | £848k |
| Profit (best available) | — | £984k | £848k |
| Staff costs | — | £1.5m | £1.5m |
| Employees (average) | 16 | 16 | 20 |
| Ratios | |||
| Profit margin | — | 3.7% | 3% |
| Revenue per employee | — | £1.7m | £1.4m |
| Profit per employee | — | £61.5k | £42.4k |
| Growth (year on year) | |||
| Revenue growth | — | — | ▲5.5% |
| Profit growth | — | — | ▼13.9% |
| Headcount growth | — | 0% | ▲25% |
| Balance sheet — indirect signals, not revenue | |||
| Cash at bank | £74.8k | £700k | £1.9m |
| Net assets | £15.5k | £1m | £1.8m |
| Fixed assets | £86.3k | £62k | £71.6k |
| Current assets | £4.1m | £4.4m | £5.6m |
| Debtors | £3.3m | £3.6m | £3.5m |
| Deferred income | £567k | £431k | £451k |
| Source | Accounts · bulk data Jun 2024 | Accounts · bulk data Jun 2024 | FullAccounts · bulk data Nov 2025 |
How the business works
- Profit margin
- 3%
- Profit ÷ revenue.
- Gross margin
- —
- Gross profit ÷ revenue. High for software and services.
- Revenue per employee
- £1.4m
- Revenue ÷ average employees.
- Profit per employee
- £42.4k
- Profit ÷ average employees.
- Cash conversion
- —
- Cash generated from operations ÷ operating profit. Needs a cash-flow statement.
- Fixed assets ÷ revenue
- 0.3%
- Capital intensity. Low = capital-light, cheaper to start.
- Deferred income ÷ revenue
- 1.6%
- Customers paying upfront (subscriptions, deposits). Approximate when combined with accruals.
- Debtors ÷ revenue
- 12.5%
- Money owed by customers. Low = customers pay quickly.
Balance-sheet signals
Year-on-year changes in filed balance-sheet items. They can hint at momentum (or investment) but are not revenue or profit and must not be read as such.
- Net assets
- ▲85%
- Now £1.8m
- Cash at bank
- ▲173%
- Now £1.9m
- Headcount
- ▲25%
- Now 20
- Deferred income
- ▲5%
- Now £451k
- Fixed assets
- ▲15%
- Now £71.6k
Deferred income is reported together with accruals in this filing (“accruals and deferred income”), so it is an approximate signal only.
Similar profitable businesses
- Fairview Health LimitedHarrow · Wholesale of pharmaceutical goods
- Revenue
- £27.8m
- Profit
- £2.7m
- Staff
- 94
- Hameln Pharma LtdGloucester · Wholesale of pharmaceutical goods
- Revenue
- £28.6m
- Profit
- £2.9m
- Staff
- 32
- Greiner Bio-One LimitedStonehouse · Wholesale of pharmaceutical goods
- Revenue
- £29.3m
- Profit
- £958k
- Staff
- 39
- Adelphi (Tubes) LimitedHaywards Heath · Wholesale of pharmaceutical goods
- Revenue
- £29.6m
- Profit
- £8.7m
- Staff
- 31
- Flamingo Pharma (UK) LtdHarrow · Wholesale of pharmaceutical goods
- Revenue
- £25.5m
- Profit
- £329k
- Staff
- 14
- Pharmaceuticals Direct LimitedWholesale of pharmaceutical goods
- Revenue
- £25.2m
- Profit
- £1.3m
- Staff
- 26
Sources
Latest figures from FullAccounts for the year to 28 Feb 2025 (profit £848k), from the Companies House accounts bulk data published Nov 2025. Spotted an error? Request a correction.
Contains public sector information from Companies House licensed under the Open Government Licence v3.0. Data from Companies House, © Crown copyright. View the licence.